Providing patient care is one of the toughest jobs on Earth.
Among many other challenges, you face a daily struggle to strike a balance between patient comfort and patient needs.
When you’re selecting securement for Peripherally Inserted Central Catheters (PICCs) or Central Venous Catheters (CVCs), it can be hard to find a product that is both reliably secure and comfortable for the patients who need it.
However, as a clinician, you always hope to avoid the clinical, emotional and financial costs of catheter related complications.
On this front, it is worth it to compare the options available to you.
Comparing PICC/CVC securement systems: 3M™ TegadermTM PICC/CVC Securement System vs. Statlock®
To see which PICC/CVC Securement system prevented more catheter dislodgements, see the test in action, as performed on true-to-life models (note: although the models are convincing, no real people were used/injured in this test).
The test results are clear: 3M™ TegadermTM PICC/CVC Securement System has been proven to prevent more catheter dislodgments than StatLock®.
The 3M™ TegadermTM PICC/CVC Securement Device + Tegaderm™ I.V. Advanced Dressing Designed with Clinicians and Patients in Mind
The 3M™ PICC/CVC Securement System features:
- A securement device with silicone adhesive that balances secure adhesion with gentleness to skin.
- A 3M™ Tegaderm™ I.V. Advanced Dressing specifically designed to enhance securement of the device.
The key benefits of which are:
- A balance of reliable adhesion with gentleness to the skin
- Easier to apply and remove then other leading securement devices
- Helps eliminate the overall cost of care
- Patient comfort and mobility
- Up to 7 day wear time (3M Data on File)
Watch below for a complete overview of the features and benefits of this product.
Now Available: An additional version of the 3M ™ TegadermTM PICC/CVC Securement System
An additional version of the 3M™ PICC/CVC Securement System includes a chlorhexidine gluconate gel pad and provides the additional benefit of being indicated to reduce Catheter-related bloodstream infections (CRBSIs) and catheter colonization.
This product is clinically proven to reduce CRBSI in patients with central venous and/or arterial catheters by 60 per cent.
To request that a local 3M sales representative contact you to provide further information, please fill out the form below.
About the AuthorFollow on Twitter Follow on Linkedin Visit Website More From 3M Canada